⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HCWB News
HCW Biologics Inc. Common Stock
Form 8-K
sec.gov
HCWB
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
globenewswire.com
HCWB
Form 8-K
sec.gov
HCWB
Form 8-K
sec.gov
HCWB
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter
globenewswire.com
HCWB
Form 8-K
sec.gov
HCWB
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026
globenewswire.com
HCWB
Form 8-K
sec.gov
HCWB
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
globenewswire.com
HCWB
Form 8-K
sec.gov
HCWB